Norgine invests £23 million in Wales site to modernize production and boost resilience for UK and European medicine supply chains.

Upperton Pharma Solutions submits MHRA application for a new Annex 1–compliant sterile manufacturing facility, expanding clinical-scale CDMO capacity for biotech and pharma companies.

Two weeks after launch, 91% of people had confirmed that they had completed the training. That level of visibility simply wasn’t possible for us before.” — Daniel Burgess, Aerogen Pharma SAN MATEO, CA ...

DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ — The safety of parenteral medicines and medical devices is heavily dependent on the rigorous ...

BioTechnique expands 3PL services with compliant storage, inventory control, and GDP‑aligned shipping for regulated ...

The use of acidic MPAs (pH 2–4) is the default in pharmaceutical testing because they suppress silanol ionization (from Si-OH to Si-O -) and improve peak shape for basic drugs. However, highly ...

ZIBO CITY, SHANDONG PROVINCE, CHINA, March 5, 2026 /EINPresswire.com/ -- The global veterinary pharmaceuticals market ...

As demands for aseptic manufacturing increase, partnerships with solutions providers will be key to ensuring safe, versatile and optimized drug containment.

As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...